Clinical Trial Update: Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex [Phase 3]

View source ↗

Summary

Phase 3 trial update on recovery of diaphragmatic function after neuromuscular blockade and sugammadex has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diaphragmatic Dysfunction
• Muscle Fatigue
• Muscle Weakness

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Diaphragmatic Dysfunction, Muscle Weakness | Phase 3 | Status: COMPLETED | Results posted: 2018-10-24